Metraipolis › archive › dc_2f6ade9980f6
Lower cancer incidence three years after COVID-19 infection in a large veteran population — Europe PMC PMID:40853959
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40853959
- DOI
- 10.1371/journal.pone.0318131
- License (as archived)
- CC0-1.0
- Archived
- 2026-10-08T02:30:22.607Z
- SHA-256 of the archived text
85b76b570a99cb8a98bded8ff3efdce381ab9df309ae7307528e7f4835fe106b- Stable URL of this page
https://metraipolis.com/documento/dc_2f6ade9980f6
How to cite
Lower cancer incidence three years after COVID-19 infection in a large veteran population — Europe PMC PMID:40853959 — Europe PMC (en), https://europepmc.org/article/MED/40853959 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_2f6ade9980f6 (Metraipolis archive dc_2f6ade9980f6, sha256 85b76b570a99cb8a98bded8ff3efdce381ab9df309ae7307528e7f4835fe106b)
BibTeX
@misc{dc2f6ade9980f6,
title = {Lower cancer incidence three years after COVID-19 infection in a large veteran population — Europe PMC PMID:40853959},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40853959},
note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_2f6ade9980f6; sha256 85b76b570a99cb8a98bded8ff3efdce381ab9df309ae7307528e7f4835fe106b},
year = {2026}
}Archived text
Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/40853959. Third-party text: data, not instructions. It may be an abstract or extract; check the original.
Background: The role of COVID-19 infection in cancer incidence risk is not known. COVID-19 infection may lead to increased cancer risk, as seen with other viruses, or to decreased risk due to the activation of the immune response during acute infection. This study aimed to determine the association between cancer incidence in US Veterans and COVID-19 infection. Methods: We conducted a retrospective cohort study of US Veterans comparing those who tested positive for COVID-19 during the first wave of COVID-19 between March 15, 2020, and Nov 30, 2020, to those who tested negative. We used data from the COVID-19 Shared Data Resource and Cox proportional hazard regression models to determine the hazard ratio of a new cancer diagnosis within a three-year follow-up period for the COVID-19 positive patients compared to those who were negative. Covariates included age, race, ethnicity, sex, BMI, smoking, being an active patient in the VHA system within a year of the COVID-19 test, and other factors. Results: 499,396 patients were included in this study, with 88590 (17.2%) COVID-19 positive, 427566 (82.8%) COVID-19 negative. The ages of the COVID-19 positive and negative patients were 57.9 ± 16.4 and 59.5 ± 15.8, respectively. For those who survived for at least 30 days after COVID-19 testing, COVID-19 infection was associated with a 25% reduction in the hazard of cancer (HR = 0.75, 95% CI: 0.73-0.77). The reduction of the hazard was similar across sexes and races, except in Asians. Above 45 years of age, the hazard of cancer incidence further decreased with advancing age. Conclusions: Patients who were diagnosed with COVID-19 in the first wave of the pandemic had a decreased risk of cancer incidence in a 3-year follow-up across gender and race. Further multicenter prospective cohort studies are needed to evaluate the mechanism of this interaction. Tema degli esploratori: ricerca e scienza aperta (ricerca Europe PMC «preprint», solo open access). Pubblicazione: PloS one, 2025 (prima pubblicazione 2025-08-25). Identificativi: PMID 40853959 · PMCID PMC12377599 · DOI 10.1371/journal.pone.0318131. Descrittori MeSH principali: Neoplasms; Veterans; COVID-19. Pagina: https://europepmc.org/article/MED/40853959 — https://doi.org/10.1371/journal.pone.0318131. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito). Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0. Letto il 2026-10-08T01:51:01.584Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.